EGFR and non-small cell lung carcinoma: The autographic electropherogram of protein extracts from these NSCLC cell lines that were pretreated with morpholino-[131I]IPQA demonstrated the preferential convent binding of morpholino-[131I]IPQA to the cells with L858R and E746-A750 del EGFR mutations (Figure 2(a)) These bands were correspondent with the 172 kDa protein band stained with anti-EGFR antibody (Figure 2(b)).